Jeffrey Millard
About Jeffrey Millard
Jeffrey Millard is the Chief Operating Officer with extensive industrial experience in CMC and a PhD in Pharmaceutical Sciences from the University of Arizona.
Jeffrey Millard Title and Role
Jeffrey Millard holds the position of Chief Operating Officer. In this role, he oversees the operational aspects of the organization, bringing strategic focus and direction to various departments under his supervision. His responsibilities likely include managing day-to-day operations, optimizing processes, and ensuring the effective implementation of organizational goals.
Jeffrey Millard Education and Expertise
Jeffrey Millard earned his PhD in Pharmaceutical Sciences from the University of Arizona. This advanced degree has equipped him with a deep understanding of the pharmaceutical sciences, essential for his work in the industry. His educational background provides a strong foundation for his expertise in chemistry, manufacturing, and controls (CMC), an area in which he has substantial industrial experience.
Jeffrey Millard Industrial Experience in CMC
Jeffrey Millard possesses significant industrial experience in CMC (chemistry, manufacturing, and controls). His expertise in CMC spans various stages of the drug development process, from discovery and in-licensing to the commercial launch of products. This experience is critical in ensuring that pharmaceutical products meet regulatory and quality standards throughout their lifecycle.
Jeffrey Millard IND Submissions
Jeffrey Millard has successfully submitted seven Investigational New Drug (IND) applications across different regulatory bodies, including CDER, CBER, and IMPDs. These submissions are crucial steps in the drug development process, allowing new pharmaceuticals to be tested in clinical trials. His ability to navigate and manage IND submissions reflects his proficiency in regulatory affairs and his commitment to advancing new therapies.
Jeffrey Millard CMC Project Direction
Jeffrey Millard has directed CMC efforts from the stages of discovery and in-licensing through to the commercial launch of products. His role in directing these efforts involves ensuring the proper integration of chemistry, manufacturing, and controls activities within the broader development and commercialization processes. This leadership is vital for the successful transition of pharmaceutical products from laboratory research to market readiness.